• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share
November 20, 2020
Contact: HHS Press Office
[email protected]

Statement from HHS Chief of Staff Brian Harrison on Unapproved Drugs Initiative

Today, the Department of Health and Human Services (HHS) through a Notice published in the Federal Register announced the withdrawal of guidance documents issued as part of the Unapproved Drugs Initiative. HHS Chief of Staff Brian Harrison issued the following statement:

“We are committed to putting American patients first by ending government programs like the Unapproved Drugs Initiative that, while well-intentioned, have distorted markets and produced the unintended consequences of price spikes and drug shortages.” – HHS Chief of Staff Brian Harrison

Read the Frequently Asked Questions Regarding the Department of Health and Human Services’ Announcement on the Unapproved Drugs Initiative*

*This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to [email protected].

Note: All HHS press releases, fact sheets and other news materials are available at https://www.hhs.gov/news.
Like HHS on Facebook, follow HHS on Twitter @HHSgov, and sign up for HHS Email Updates.
Last revised: November 20, 2020

Subscribe to RSS

Receive latest updates

Subscribe to our RSS